LYON, France and CAMBRIDGE, Mass., June 07, 2023 (GLOBE NEWSWIRE) Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced
A new Canadian guideline recommends a risk assessment–first approach to fragility fracture screening before a bone mineral density test to facilitate shared decision-making.
Get ready to meet the incredible team of industry experts that will be joining the judging panel. We're absolutely thrilled to welcome these brilliant Skift IDEA Awards judges are carefully handpicked by the Skift team and include travel industry veterans, entrepreneurs, imagineers, and global leaders.